AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22332570 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND) for T2 cases
Number of subjects: 132
Study 22332570 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see (group WS) for T2 cases
Number of subjects: 132
Study 22332570 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND) for T2b cases (size > 3.0 cm)
Number of subjects: 132
Study 22332570 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see (group WS) for T2b cases (size > 3.0 cm)
Number of subjects: 132
Study 22332570 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND) for pathologically poor differentiation cases
Number of subjects: 132
Study 22332570 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see (group WS) for pathologically poor differentiation cases
Number of subjects: 132
Study 18281192 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Criterion A1 events
Number of subjects: 119
Study 18281192 — intervention group
Group type: COMPARATOR
Intervention: Criterion A1 events
Number of subjects: 119
Study 16808576 — intervention group
Group type: EXPERIMENTAL
Intervention: LED curing devices with soft start mode
Number of subjects: 20
Study 16808576 — intervention group
Group type: COMPARATOR
Intervention: Halogen light curing technique
Number of subjects: 20
Study 12393110 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-ketamine (1-1.5 mg/kg)
Number of subjects: 120
Study 12393110 — intervention group
Group type: COMPARATOR
Intervention: Propofol-fentanyl (3-5 microg/kg)
Number of subjects: 120
Study 12393110 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-ketamine
Number of subjects: 120
Study 12393110 — intervention group
Group type: COMPARATOR
Intervention: Propofol-fentanyl
Number of subjects: 120
Study 10326078 — intervention group
Group type: EXPERIMENTAL
Intervention: Bootstrapping methodology for estimating confidence intervals for cost-effectiveness ratios
Number of subjects: 0
Study 7843782 — intervention group
Group type: COMPARATOR
Intervention: 20 mg enalapril once daily in the morning for 5 days
Number of subjects: 79
Study 7843782 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 5 days
Number of subjects: 79
Study 2162692 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily diary card during chemotherapy
Number of subjects: 53
Study 2162692 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation
Number of subjects: 53
Study 2162692 — intervention group
Group type: COMPARATOR
Intervention: Comparison with nurse ratings, EORTC questionnaire, Spitzer quality of life index
Number of subjects: 53
Study 412877 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular meptazinol
Number of subjects: 0
Study 412877 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 0
Study 412877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29925090 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate
Number of subjects: 0
Study 29925090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27682642 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar vessel-sealing device (BVSD)
Number of subjects: 380
Study 27682642 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonically activated device (UAD)
Number of subjects: 380
Study 27682642 — intervention group
Group type: COMPARATOR
Intervention: Control group (no energy device used)
Number of subjects: 380
Study 25456014 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention aimed at increasing colorectal cancer (CRC) screening
Number of subjects: 5628
Study 25456014 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 5628
Study 22868780 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific guides (PSG)
Number of subjects: 111
Study 22868780 — intervention group
Group type: COMPARATOR
Intervention: Computer-assisted navigation (CAN)
Number of subjects: 111
Study 20610229 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient worsening renal function (WRF)
Number of subjects: 467
Study 20610229 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent worsening renal function (WRF)
Number of subjects: 467
Study 20610229 — intervention group
Group type: COMPARATOR
Intervention: Stable renal function
Number of subjects: 467
Study 20610229 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient WRF vs. Persistent WRF
Number of subjects: 467
Study 19040004 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal navigation with intra‐operative 3D‐imaging system
Number of subjects: 401
Study 19040004 — intervention group
Group type: COMPARATOR
Intervention: Traditional method of pedicle screw fixation
Number of subjects: 401
Study 17262997 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of Fas mRNA in RR MS patients (n=13)
Number of subjects: 25
Study 17262997 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of FasL mRNA in SP MS patients (n=12)
Number of subjects: 25
Study 14662245 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab plus IRA stenting
Number of subjects: 400
Study 14662245 — intervention group
Group type: COMPARATOR
Intervention: Stent only
Number of subjects: 400
Study 10541446 — intervention group
Group type: COMPARATOR
Intervention: Daily supplementation with antioxidant vitamins (vitamin C, 120 mg, vitamin E, 30 mg, beta‐carotene, 6 mg) and minerals (selenium, 100 microg, and zinc, 20 mg)
Number of subjects: 12735
Study 10541446 — intervention group
Group type: COMPARATOR
Intervention: Daily supplementation with antioxidant vitamins and minerals
Number of subjects: 12735
Study 8902310 — intervention group
Group type: EXPERIMENTAL
Intervention: Days with mean temperature > 20 degrees C
Number of subjects: 2877
Study 8902310 — intervention group
Group type: COMPARATOR
Intervention: Days with temperature < or = 20 degrees C
Number of subjects: 2877
Study 1684314 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH after saline infusion (Day 2)
Number of subjects: 7
Study 1684314 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin infusion followed by saline (Day 3)
Number of subjects: 7
Study 1684314 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH with somatostatin withdrawal (Day 4)
Number of subjects: 7
Study 1684314 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Day 1)
Number of subjects: 7
Study 6750779 — intervention group
Group type: EXPERIMENTAL
Intervention: Microencapsulated acetylsalicylic acid (ASA) with pH-dependent release (Reumyl)
Number of subjects: 18
Study 6750779 — intervention group
Group type: EXPERIMENTAL
Intervention: Microencapsulated acetylsalicylic acid (ASA) with time-dependent release (Acetard)
Number of subjects: 18
Study 31701388 — intervention group
Group type: EXPERIMENTAL
Intervention: You-Me-Us healthy relationship program
Number of subjects: 911
Study 31701388 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 911
Study 30002007 — intervention group
Group type: EXPERIMENTAL
Intervention: Best usual primary care plus treatment with oseltamivir for 5 days
Number of subjects: 2500
Study 30002007 — intervention group
Group type: COMPARATOR
Intervention: Best usual primary care
Number of subjects: 2500
Study 27936189 — intervention group
Group type: EXPERIMENTAL
Intervention: Peppy comments from attending physicians (e.g., 'Hope you have a quiet day!')
Number of subjects: 25
Study 27936189 — intervention group
Group type: COMPARATOR
Intervention: No peppy comments from attending physicians (control group)
Number of subjects: 25
Study 24793658 — intervention group
Group type: EXPERIMENTAL
Intervention: H‐NPPV
Number of subjects: 64
Study 24793658 — intervention group
Group type: COMPARATOR
Intervention: IMV
Number of subjects: 64
Study 22286847 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimists (defined by Life Orientation Test - Revised)
Number of subjects: 284
Study 22286847 — intervention group
Group type: EXPERIMENTAL
Intervention: Pessimists (defined by Life Orientation Test - Revised)
Number of subjects: 284
Study 22286847 — intervention group
Group type: COMPARATOR
Intervention: Depressed patients
Number of subjects: 284
Study 20146365 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled tobramycin
Number of subjects: 15
Study 20146365 — intervention group
Group type: COMPARATOR
Intervention: Systemic antibiotics (intravenous ceftazidime and tobramycin)
Number of subjects: 15
Study 18953269 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Number of subjects: 0
Study 18953269 — intervention group
Group type: EXPERIMENTAL
Intervention: New NNRTIs
Number of subjects: 0
Study 15898539 — intervention group
Group type: EXPERIMENTAL
Intervention: Different texture types used in slant discrimination performance.
Number of subjects: 0
Study 12913771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tormentil root extract (3 drops per year of life, three times daily for up to 5 days)
Number of subjects: 40
Study 12913771 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 drops per year of life, three times daily for up to 5 days)
Number of subjects: 40
Study 12913771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tormentil root extract
Number of subjects: 40
Study 12913771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11783170 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue decoction (Group B)
Number of subjects: 62
Study 8865768 — intervention group
Group type: EXPERIMENTAL
Intervention: Text presentation rate of 55 words/min
Number of subjects: 32
Study 8865768 — intervention group
Group type: EXPERIMENTAL
Intervention: Text presentation rate of 120 words/min
Number of subjects: 32
Study 8865768 — intervention group
Group type: EXPERIMENTAL
Intervention: Text presentation rate of 216 words/min
Number of subjects: 32
Study 8865768 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced dioptric blur (0.5, 1.0, or 1.5 diopters)
Number of subjects: 32
Study 8865768 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning English as a second language
Number of subjects: 32
Study 1511566 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox (250 mg three times per day)
Number of subjects: 48
Study 1511566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 6421015 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 mg NTG
Number of subjects: 28
Study 6421015 — intervention group
Group type: COMPARATOR
Intervention: Control (no NTG)
Number of subjects: 28
Study 30824339 — intervention group
Group type: EXPERIMENTAL
Intervention: GHB (20 mg/kg)
Number of subjects: 15
Study 30824339 — intervention group
Group type: EXPERIMENTAL
Intervention: GHB (35 mg/kg)
Number of subjects: 15
Study 30824339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 30243751 — intervention group
Group type: EXPERIMENTAL
Intervention: CRST (Cardiorespiratory Synchronization Training)
Number of subjects: 96
Study 30243751 — intervention group
Group type: COMPARATOR
Intervention: RT (Relaxation Training)
Number of subjects: 96
Study 30243751 — intervention group
Group type: COMPARATOR
Intervention: C (Control)
Number of subjects: 96
Study 26389858 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-based video clip on urinary catheterization (unlimited viewing for 1 week)
Number of subjects: 71
Study 26389858 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mobile-based video clip)
Number of subjects: 71
Study 24974383 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-stroke dementia and vascular dementia
Number of subjects: 90
Study 24974383 — intervention group
Group type: COMPARATOR
Intervention: Post-stroke patients with no dementia
Number of subjects: 90
Study 24974383 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-stroke and vascular dementia
Number of subjects: 90
Study 24974383 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsolateral prefrontal cortex pyramidal cells
Number of subjects: 90
Study 22480799 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitality diet (VD)
Number of subjects: 95
Study 22480799 — intervention group
Group type: COMPARATOR
Intervention: Healthy diet (HD)
Number of subjects: 95
Study 22480799 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 95
Study 20416390 — intervention group
Group type: EXPERIMENTAL
Intervention: NVA237 100 microg
Number of subjects: 281
Study 20416390 — intervention group
Group type: EXPERIMENTAL
Intervention: NVA237 200 microg
Number of subjects: 281
Study 20416390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study 17651636 — intervention group
Group type: EXPERIMENTAL
Intervention: Management by minimization of the induced sputum EOS (Group A, n = 20)
Number of subjects: 41
Study 17651636 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical guidelines (Group B, n = 21)
Number of subjects: 41
Study 17651636 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 41
Study 17651636 — intervention group
Group type: COMPARATOR
Intervention: Group B
Number of subjects: 41
Study 15897211 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-oriented educational programme on assessment, treatment and management of somatisation (The Extended Reattribution and Management Model)
Number of subjects: 43
Study 15897211 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 43
Study 12357515 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Fr guiding catheter
Number of subjects: 171
Study 12357515 — intervention group
Group type: COMPARATOR
Intervention: 6 Fr guiding catheter
Number of subjects: 171
Study 10080213 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost eyedrops once daily
Number of subjects: 36
Study 10080213 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol eyedrops twice daily
Number of subjects: 36
Study 7956634 — intervention group
Group type: EXPERIMENTAL
Intervention: Premixed insulins
Number of subjects: 27
Study 7956634 — intervention group
Group type: COMPARATOR
Intervention: Patient-mixed insulins
Number of subjects: 27
Study 7956634 — intervention group
Group type: EXPERIMENTAL
Intervention: Pen-type insulin syringes
Number of subjects: 27
Study 2832328 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT (0.1-80 ng/kg/min)
Number of subjects: 20
Study 2832328 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (5-125 ng/kg/min)
Number of subjects: 20
Study 2832328 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (125 ng/kg/min) with 5-HT (1 ng/kg/min)
Number of subjects: 20
Study 2832328 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (50 ng/kg/min) with 5-HT (80 ng/kg/min)
Number of subjects: 20
Study 30033695 — intervention group
Group type: COMPARATOR
Intervention: Simple Triage and Rapid Treatment (START) system
Number of subjects: 64
Study 30033695 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital Advanced Triage Model (META)
Number of subjects: 64
Study 27329894 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive self-ligating brackets
Number of subjects: 50
Study 27329894 — intervention group
Group type: COMPARATOR
Intervention: Conventional brackets
Number of subjects: 50
Study 24885637 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment
Number of subjects: 0
Study 24885637 — intervention group
Group type: COMPARATOR
Intervention: Operative treatment
Number of subjects: 0
Study 22616411 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based animated pedagogical agents
Number of subjects: 0
Study 22616411 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 20195215 — intervention group
Group type: EXPERIMENTAL
Intervention: Total disc replacement
Number of subjects: 155
Study 20195215 — intervention group
Group type: COMPARATOR
Intervention: Fusion surgery
Number of subjects: 155
Study 20195215 — intervention group
Group type: EXPERIMENTAL
Intervention: Active adverse events related to the study intervention
Number of subjects: 155
Study 18401285 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (IT‐Dex + HDPT)
Number of subjects: 51
Study 18401285 — intervention group
Group type: COMPARATOR
Intervention: HDPT alone
Number of subjects: 51
Study 18401285 — intervention group
Group type: COMPARATOR
Intervention: IT‐Dex alone
Number of subjects: 51
Study 15844844 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at the P6 point
Number of subjects: 111
Study 15844844 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 111
Study 15844844 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 111
Study 12219782 — intervention group
Group type: EXPERIMENTAL
Intervention: Location-guided screening (LGS) using the AutoPap system with the SlideWizard 2 automated review microscopy station
Number of subjects: 1275
Study 12219782 — intervention group
Group type: COMPARATOR
Intervention: Current practice (CP) manual screening
Number of subjects: 1275
Study 12219782 — intervention group
Group type: EXPERIMENTAL
Intervention: Location-guided screening (LGS)
Number of subjects: 1275
Study 10633964 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprapubic catheter (Group A)
Number of subjects: 109
Study 10633964 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral catheter (Group B)
Number of subjects: 109
Study 10633964 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral cleansing (Group C)
Number of subjects: 109
Study 10633964 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 109
Study 8653235 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical gel preparation of adrenaline (1:2000) and cocaine (4.7%)
Number of subjects: 107
Study 8653235 — intervention group
Group type: COMPARATOR
Intervention: 1% plain lignocaine
Number of subjects: 107
Study 2061364 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate at 0.15 mg/kg
Number of subjects: 30
Study 2061364 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate at 0.50 mg/kg
Number of subjects: 30
Study 6669629 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg) for 14 nights
Number of subjects: 5
Study 6669629 — intervention group
Group type: COMPARATOR
Intervention: Nitrazepam (5 mg) for 14 nights
Number of subjects: 5
Study 30369062 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab administered on-demand every 4 weeks
Number of subjects: 120
Study 30369062 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab administered on-demand every 8 weeks
Number of subjects: 120
Study 28438121 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg elevation (LE)
Number of subjects: 150
Study 28438121 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 150
Study 27097735 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% carbon dioxide (CO2)‐enriched air mixture
Number of subjects: 90
Study 27097735 — intervention group
Group type: COMPARATOR
Intervention: Compressed room air
Number of subjects: 90
Study 24443923 — intervention group
Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg/day
Number of subjects: 0
Study 24443923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24443923 — intervention group
Group type: COMPARATOR
Intervention: Lubricants (used as needed)
Number of subjects: 0
Study 23200183 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg
Number of subjects: 540
Study 23200183 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 650 mg
Number of subjects: 540
Study 23200183 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 1000 mg or 650 mg
Number of subjects: 540
Study 23200183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 19653745 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal stimuli (auditory and vibrotactile)
Number of subjects: 24
Study 19653745 — intervention group
Group type: COMPARATOR
Intervention: Unimodal auditory stimuli
Number of subjects: 24
Study 17615999 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin (150 mg)
Number of subjects: 10
Study 17615999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 14694252 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with SCD
Number of subjects: 64
Study 11165421 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin
Number of subjects: 10477
Study 11165421 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 10477
Study 11165421 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 10477
Study 11165421 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 10477
Study 11165421 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 10477
Study 11165421 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 10477
Study 9829607 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented preterm infant formula from postnatal day 3 to day 30
Number of subjects: 68
Study 9829607 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 68
Study 9829607 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 68
Study 7799495 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening mammography
Number of subjects: 500000
Study 7799495 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastectomy or breast-conserving surgery with radiation therapy
Number of subjects: 500000
Study 7799495 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy
Number of subjects: 500000
Study 7799495 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical follow-up without routine testing for metastatic disease
Number of subjects: 500000
Study 2136324 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (10 g cumulative dose)
Number of subjects: 19
Study 2136324 — intervention group
Group type: COMPARATOR
Intervention: Control group (no amiodarone)
Number of subjects: 19
Study 7391988 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.15 mg over 10 min)
Number of subjects: 24
Study 28029485 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu injection (SFI)
Number of subjects: 157
Study 28029485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157